Senescence-associated-β-galactosidase staining following traumatic brain injury in the mouse cerebrum
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Primary and secondary traumatic brain injury (TBI) can cause tissue damage by inducing cell death pathways including apoptosis, necroptosis, and autophagy. However, similar pathways can also lead to senescence. Senescent cells secrete senescence-associated secretory phenotype proteins following persistent DNA damage response signaling, leading to cell disorders. TBI initially activates the cell cycle followed by the subsequent triggering of senescence. This study aims to clarify how the mRNA and protein expression of different markers of cell cycle and senescence are modulated and switched over time after TBI. We performed senescence-associated-β-galactosidase (SA-β-gal) staining, immunohistochemical analysis, and real-time PCR to examine the time-dependent changes in expression levels of proteins and mRNA, related to cell cycle and cellular senescence markers, in the cerebrum during the initial 14 days after TBI using a mouse model of controlled cortical impact (CCI). Within the area adjacent to the cerebral contusion after TBI, the protein and/or mRNA expression levels of cell cycle markers were increased significantly until 4 days after injury and senescence markers were significantly increased at 4, 7, and 14 days after injury. Our findings suggested that TBI initially activated the cell cycle in neurons, astrocytes, and microglia within the area adjacent to the hemicerebrum contusion in TBI, whereas after 4 days, such cells could undergo senescence in a cell-type-dependent manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous markers of senescence (including p21, p16Ink4a, γ-H2A.X, and TAF/TIF) have been identified in skin cell types, such as keratinocytes and fibroblasts (Fig. 2 B), in conditions such as injury, aging, and accelerated aging14,54–57.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [57]
Experimental — accuracy not yet measuredIn the citing paper
“accumulation of DNA damage has been reported in various models of mTBI [3, 123, 151]”
From Early onset senescence and cognitive impairment in a murine model of repeated mTBI (2021) · cites this paper as [151]
In the citing paper
“More recently, markers of senescence were shown to be elevated in a mouse model of mTBI [153]”
From DNA repair deficiency and senescence in concussed professional athletes involved in contact sports (2019) · cites this paper as [153]
In the citing paper
“In the context of TBI, markers of senescence have been shown to elevate in microglia and astrocytes following a controlled cortical impact protocol [153].”
From DNA repair deficiency and senescence in concussed professional athletes involved in contact sports (2019) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915
Stein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825
Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation
Strzalka, W., & Ziemienowicz, A. (2011) · Annals of Botany · doi:10.1093/aob/mcq243 · Cited by 784
Regulation and function of the p53 tumor suppressor protein
Ryan, K. M., Phillips, A. C., & Vousden, K. H. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00216-7 · Cited by 721
Effect of Three Types of Mixed Anesthetic Agents Alternate to Ketamine in Mice
KAWAI, S., TAKAGI, Y., KANEKO, S., & KUROSAWA, T. (2011) · Experimental Animals · doi:10.1538/expanim.60.481 · Cited by 580
Research works printed but not linked: 1
- N Ohtani, 2015, Two faces of cellular senescence—SASP may promotes inflammation and cancer, Journal of Clinical and Experimental Medicine, 253, 753
Cited by
Guidelines for minimal information on cellular senescence experimentation in vivo
Ogrodnik, M., Carlos Acosta, J., Adams, P. D., d’Adda di Fagagna, F., Baker, D. J., Bishop, C. L., Chandra, T., Collado, M., Gil, J., Gorgoulis, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.059 · Cited by 376
de Mera-Rodríguez, J. A., Álvarez-Hernán, G., Gañán, Y., Martín-Partido, G., Rodríguez-León, J., & Francisco-Morcillo, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.623175 · Cited by 123
“…have been reported to occur during development of the vertebrate retina (Cook et al., 1998; Knabe et al., 2000; Péquignot et al., 2003; Francisco-Morcillo et al., 2004, 2014; RodríguezGallardo et al., 2005; Chavarría et al., 2007, 2013; Valenciano et al., 2009; Bejarano-Escobar et al., 2011, 2013).”
BackgroundCellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Masaldan, S., Belaidi, A. A., Ayton, S., & Bush, A. I. (2019) · Pharmaceuticals · doi:10.3390/ph12020093 · Cited by 102
“, traumatic brain injury following controlled cortical impact [90]) stressors.”
BackgroundJoseph, C., Mangani, A. S., Gupta, V. B., Chitranshi, N., Shen, T., Dheer, Y., Devaraj, K. B., Mirzaei, M., You, Y., Graham, S. L., et al. (2020) · Aging and Disease · doi:10.14336/ad.2019.0923 · Cited by 108
“Widespread cell cycle stimulation and associated neuronal death was observed in rat brains subjected to traumatic injury [185, 186].”
BackgroundTargeting cellular senescence in cancer and aging: roles of p53 and its isoforms
Beck, J., Turnquist, C., Horikawa, I., & Harris, C. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa071 · Cited by 92
“For example, the application of cellular stress, such as that induced by radiotherapy or traumatic brain injury, may induce DNA damage, oxidative stress and inflammation, dramatically increase a tissue’s senescent cell burden and overwhelm the tissue’s ability to target and remove senescent cells (8,45,89,93,94).”
BackgroundReactive gliosis in traumatic brain injury: a comprehensive review
Amlerova, Z., Chmelová, M., Anděrová, M., & Vargová, L. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1335849 · Cited by 94
Evidence of sex differences in cellular senescence
Ng, M., & Hazrati, L.-N. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.014 · Cited by 78
“, 2019), as well as in mice models of mTBI (Tominaga et al., 2019), senescence markers are significantly increased compared to non-injured controls.”
Cellular senescence in brain aging and cognitive decline
Shafqat, A., Khan, S., Omer, M. H., Niaz, M., Albalkhi, I., AlKattan, K. M., Yaqinuddin, A., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281581 · Cited by 86
“…and SASP components IL-1 β , IL-6, CXCL1, and CCL8 are elevated in the brains of repeated TBI mouse models displaying cognitive deficits and in post-mortem brain samples of individuals with a history of repeated concussions (Tominaga et al., 2019; Schwab et al., 2019a,b; Mester et al., 2021).”
BackgroundCellular Senescence: Mechanisms, Morphology, and Mouse Models
Beck, J. A., Horikawa, I., & Harris, C. C. (2020) · Veterinary Pathology · doi:10.1177/0300985820943841 · Cited by 87
“Finally, mouse models with deficient DNA damage repair mechanisms or models of traumatic injury, such as traumatic brain injury or posttraumatic osteoarthritis, may be used to investigate the roles of premature or stress-induced senescence in injured tissues.(50,53,65,118,140) These experimental models demonstrate the…”
BackgroundTherapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
Astrocyte senescence and SASP in neurodegeneration: tau joins the loop
Ungerleider, K., Beck, J., Lissa, D., Turnquist, C., Horikawa, I., Harris, B. T., & Harris, C. C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1909260 · Cited by 71
“Previously, we and others have shown increased numbers of senescent cells, including senescent astrocytes, in brain tissues from patients with neurodegenerative tauopathies [8,25,27,70].”
BackgroundUntangling senescent and damage‐associated microglia in the aging and diseased brain
Ng, P. Y., McNeely, T. L., & Baker, D. J. (2023) · The FEBS Journal · doi:10.1111/febs.16315 · Cited by 68
Acute ischemic stroke triggers a cellular senescence-associated secretory phenotype
Torres-Querol, C., Torres, P., Vidal, N., Portero‐Otín, M., Arqué, G., & Purroy, F. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-95344-5 · Cited by 64
Schwab, N., Taskina, D., Leung, E., Innes, B. T., Bader, G. D., & Hazrati, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1027116 · Cited by 60
“These findings support previous studies by our lab and others showing evidence of DNA damage and cellular senescence after rmTBI (Ritzel et al., 2019; Schwab et al., 2019, 2021; Tominaga et al., 2019).”
BackgroundResultInfluentialInflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Lu, Y., Jarrahi, A., Moore, N. D., Bartoli, M., Brann, D. W., Baban, B., & Dhandapani, K. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106090 · Cited by 54
“Moderate-severe TBI increased cell cycle markers and the number of senescence associated beta-galactosidase (SA-β -Gal) positive cells, a gold standard marker of cellular senescence, in the ipsilateral hemisphere for one-month post-injury (Tominaga et al., 2019; Schwab et al., 2021).”
BackgroundDNA repair deficiency and senescence in concussed professional athletes involved in contact sports
Schwab, N., Grenier, K., & Hazrati, L.-N. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0822-3 · Cited by 47
Ritzel, R. M., Li, Y., Lei, Z., Carter, J., He, J., Choi, H., Khan, N., Li, H., Allen, S., Lipinski, M. M., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00562-y · Cited by 46
Chun, C., Smith, A. S. T., Kim, H., Kamenz, D. S., Lee, J. H., Lee, J. B., Mack, D. L., Bothwell, M., Clelland, C. D., & Kim, D.-H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120700 · Cited by 45
Adedokun, K. A., Imodoye, S. O., Bello, I. O., Lanihun, A.-A. A., & Bello, I. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90593-0.00017-4 · Cited by 64
Early onset senescence and cognitive impairment in a murine model of repeated mTBI
Schwab, N., Ju, Y., & Hazrati, L.-N. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01190-x · Cited by 39
“Senescent cells accumulate with age [23, 157, 175], neurodegenerative disease and cognitive decline [15], neuropsychiatric disorders [33], and have recently been discovered to accumulate after TBI [3, 123, 131, 132, 151].”
BackgroundResultBlázquez-Prieto, J., Huidobro, C., López-Alonso, I., Amado‐Rodríguez, L., Martín-Vicente, P., López‐Martínez, C., Crespo, I., Pantoja, C., Fernández-Marcos, P. J., Serrano, M., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.01.008 · Cited by 43
“The acute nature of our model and its short-term lethality does not allow the identification of canonical senescence markers such as Senescence-associated b-galactosidase, as these require from days to weeks to be D252X X positive.(37) D253X X However, we identified a set of early markers including changes in chromati…”
BackgroundA geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Gonzales, M. M., Krishnamurthy, S., Garbarino, V. R., Daeihagh, A. S., Gillispie, G. J., Deep, G., Craft, S., & Orr, M. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111589 · Cited by 38
Shahapal, A., Cho, E. B., Yong, H. J., Jeong, I., Kwak, H., Lee, J. K., Kim, W., Kim, B., Park, H., Lee, W. S., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00917 · Cited by 39
Wang, J., Lu, Y., Carr, C., Dhandapani, K. M., & Brann, D. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1227705 · Cited by 43
“This finding agrees with previous studies that identified senescent astrocytes and microglia in the injured cortex within days after TBI (Kozlova and Lukanidin, 2002; Ritzel et al., 2019; Tominaga et al., 2019), as well as in the aging and AD brain (Bhat et al.”
BackgroundResultAutophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 42
Cellular Senescence in Traumatic Brain Injury: Evidence and Perspectives
Schwab, N., Leung, E., & Hazrati, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.742632 · Cited by 40
Tetrandrine Ameliorates Traumatic Brain Injury by Regulating Autophagy to Reduce Ferroptosis
Liu, H., He, S., Wang, J., Li, C., Liao, Y., Zou, Q., & Chen, R. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03553-9 · Cited by 33
“TBI could result in tissue damage by inducing cellular apoptosis, necrosis, and autophagy [26].”
BackgroundAge-Related Alterations in Immune Function and Inflammation: Focus on Ischemic Stroke
Chen, Q., Wu, M., Tang, Q., Yan, P., & Zhu, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0721-1 · Cited by 43
“A recent study has shown that the levels of SA-β-gal-positive cell staining gradually increased from 1 to 14 days and peaked at 7 days after injury in the TBI mouse model [206].”
BackgroundSenescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke
Ouvrier, B., Ismael, S., & Bix, G. J. (2024) · Pharmaceuticals · doi:10.3390/ph17030312 · Cited by 38
“Acute brain injury, such as traumatic brain injury (TBI), also causes SASP transcriptional profile in a mouse model of controlled cortical impact (CCI) [65].”
BackgroundBlast Exposure Leads to Accelerated Cellular Senescence in the Rat Brain
Arun, P., Rossetti, F., Wilder, D. M., Sajja, S., Van Albert, S. A., Wang, Y., Gist, I. D., & Long, J. B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00438 · Cited by 30
Involvement of lncRNA TUG1 in HIV-1 Tat-Induced Astrocyte Senescence
Pillai, P. P., Kannan, M., Sil, S., Singh, S., Thangaraj, A., Chivero, E. T., Dagur, R. S., Tripathi, A., Hu, G., Periyasamy, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054330 · Cited by 25
Brain Cell Senescence: A New Therapeutic Target for the Acute Treatment of Ischemic Stroke
Baixauli-Martín, J., Aliena‐Valero, A., Castelló‐Ruiz, M., Burguete, M. C., López‐Morales, M. A., Muñoz‐Espín, D., Torregrosa, G., & Salom, J. B. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac048 · Cited by 25
Cellular senescence: A novel therapeutic target for central nervous system diseases
Lei, S.-Y., Qu, Y., Yang, Y.-Q., Liu, J., Zhang, Y.-F., Zhou, S., He, Q., Jin, H., Yang, Y., & Guo, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117311 · Cited by 23
Huang, Z., Xu, P., Hess, D. C., & Zhang, Q. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00457-2 · Cited by 20
Li, X., Kang, B., Eom, Y., Zhong, J., Lee, H. K., Kim, H. M., & Song, J. S. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.10.19 · Cited by 16
“29–31”
Al-Khateeb, Z. F., Boumenar, H., Adebimpe, J., Shekerzade, S., Henson, S. M., Tremoleda, J. L., & Michael-Titus, A. T. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114714 · Cited by 17
“In the case of senescence reported in TBI in adult mice, Tominaga et al. (2019) showed an increase in β -gal positive cells in the injured hemisphere from day 4 post injury, which peaked at day 7.”
BackgroundResultInfluentialWu, J., Wei, Y., Peng, Q., Zhu, J. F., Shi, H., Zhao, T., & Yuan, T. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01759-3 · Cited by 16
“Studies suggest that cells with active cell cycle machinery, particularly astrocytes, may undergo senescence [32].”
Spatio-Temporal Characterization of Cellular Senescence Hallmarks in Experimental Ischemic Stroke
Baixauli-Martín, J., Burguete, M. C., López‐Morales, M. A., Castelló‐Ruiz, M., Aliena‐Valero, A., Jover‐Mengual, T., Falahatgaroshibi, D., Torregrosa, G., & Salom, J. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052364 · Cited by 17
“These results are consistent with those previously reported in a traumatic brain injury model wherein a comparable temporal profile to ours was studied, and a gradual increase in SA-β -gal expression was observed from 24 h to 14 days post-injury [23].”
Old and Promising Markers Related to Autophagy in Traumatic Brain Injury
Livieri, T., Cuttaia, C., Vetrini, R., Concato, M., Peruch, M., Neri, M., Radaelli, D., & D’Errico, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010072 · Cited by 15
“[25] found a decrease of the molecule 3 h after TBI followed by a partial restoration at 12 h and another decrease until seventh day.”
BackgroundMethodInfluentialPhotobiomodulation therapy alleviates repeated closed head injury‐induced anxiety‐like behaviors
Chen, Z., Li, M., Wu, C., Su, Y., Feng, S., Deng, Q., Zou, P., Liu, T. C., Duan, R., & Yang, L. (2023) · Journal of Biophotonics · doi:10.1002/jbio.202300343 · Cited by 13
An in vitro senescence model of gingival epithelial cell induced by hydrogen peroxide treatment
Giri, S., Takada, A., Paudel, D., Yoshida, K., Furukawa, M., Kuramitsu, Y., Matsushita, K., Abiko, Y., & Furuichi, Y. (2021) · Odontology · doi:10.1007/s10266-021-00630-3 · Cited by 14
Raber, J., Stagaman, K., Kasschau, K. D., Davenport, C., Lopes, L. A., Nguyen, D., Torres, E. R. S., Sharpton, T. J., & Kisby, G. E. (2023) · Genes · doi:10.3390/genes14091702 · Cited by 11
“Senescence-associated-β -galactosidase (SA-β -gal) staining was performed on brain tissue sections (as described above) using a Cellular Senescence Assay Kit (CBA-230; Cell Biolabs Inc., San Diego, CA, USA) according to the manufacturer’s protocol with minor modifications [37].”
Hellani, F., Leleu, I., Saïdi, N., Martin, N., Lecœur, C., Werkmeister, E., Koffi, D., Trottein, F., Etté, H. Y., Das, B. K., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.030 · Cited by 11
“For SA-β -Gal staining on brain sections, the “ % area ” results were used as the stained level of SA-β -gal as previously described using ImageJ software (Lozano-Gerona and Garcia-Otin, 2018; Tominaga et al., 2019).”
Gu, C., Guo, T., Chen, X., Zhou, X., & Sun, Y. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01580-y · Cited by 11
“Glial activation-induced neuroinflammation after brain injury drives cellular senescence, which exacerbates inflammatory responses, aberrant metabolic changes, mitochondrial dysfunction and neuronal damage (Amgalan et al. 2022; Schwab et al. 2021; Tominaga et al. 2019).”
Liang, J., Ke, X., Yang, R., Wang, X., Du, Z., & Hu, C. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09853-5 · Cited by 9
“Hydrolysis of X-gal by β-gal releases substituted indoles that dimerize spontaneously to give an insoluble strong blue product in tissue or on growth medium (Tominaga et al. 2019).”
BackgroundKhumsri, W., Payuhakrit, W., Kongkaew, A., Chattipakorn, N., Chattipakorn, S. C., Yasom, S., & Mutirangura, A. (2024) · In Vivo · doi:10.21873/invivo.13552 · Cited by 8
Cellular senescence and nanoparticle-based therapies: Current developments and perspectives
Henschke, A., Mielcarek, A., Grześkowiak, B. F., Perrigue, P. M., Jaskot, K., Coy, E. L., & Moya, S. E. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0211 · Cited by 6
“At pH 6.0, β -galactosidase reacts with X-gal (5-bromo-4-chloro-3-indoyl-β -galactopyranoside) and, due to hydrolysis, yields a visible, usually blue product [23,24].”
BackgroundInfluentialThe study of single‐cell dynamics contributes to the evaluation of food‐derived antioxidant capacity
Xiang, X., Qing, Y., Li, S., Amakye, W. K., Wang, M., & Ren, J. (2023) · eFood · doi:10.1002/efd2.66 · Cited by 5
Tang, Y., Wang, X.-B., Zhou, Y., Wang, Y., & Ding, J.-C. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/133485 · Cited by 5
Exline, J. E., Volyanyuk, M., Lotesto, K. M., Segismundo, A. B., Byram, S. C., & Foecking, E. M. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149611 · Cited by 4
“However, senescence-associated markers peak between 3 – 7 days post-injury and approach baseline approximately 14 days after rmTBI (Al-Khateeb et al., 2024; Katano et al., 2000; Tominaga et al., 2019).”
Nehme, Z., Ghandour, F., Hijazi, A., Diab‐Assaf, M., & Karaky, R. (2024) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-024-00772-z · Cited by 3
“Images were processed using ImageJ (National Institutes of Health, Bethesda, MD, USA) as previously described (Tominaga et al. 2019).”
Kibayashi, K., Shimada, R., & Nakao, K. (2021) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2021.102205 · Cited by 3
Self-citationLima, M., de Sá, N. A. R., Novaes, M. A. S., Palomino, G. J. Q., Tetaping, G. M., Fernandes, C. C. L., Garcia, D. N., Rondina, D., Schneider, A., Figueiredo, J. R., et al. (2023) · Small Ruminant Research · doi:10.1016/j.smallrumres.2023.106985 · Cited by 3
Teawcharoensopa, C., & Srisuwan, T. (2023) · Clinical Oral Investigations · doi:10.1007/s00784-023-05455-8 · Cited by 5
“The quantification was developed at the same standard command in ImageJ software (RRID:SCR_003070, National Institutes of Health, Bethesda, MD, USA) and measured the percent area of blue-stained SA-β-gal-positive cells [45].”
Hakim, S. G., von der Gracht, A., Pries, R., Rades, D., & Steller, D. (2023) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2023.06.008 · Cited by 2
Galeza, E. (2025) · Pantao (International Journal of the Humanities and Social Sciences) · doi:10.69651/pijhss0403334 · Cited by 3
Zhao, J., Sheng, X., Ding, Y., Wen, H., Zheng, L., Sun, Y. X., He, R., Li, C., Qin, T., Wu, T., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.019 · Cited by 7
Zamani, N. I. S. M., Hamezah, H. S., Mediani, A., Ghazali, M., Sadikan, M. Z., & Jam, F. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-53311-y · Cited by 2
“Accumulating evidence from preclinical 10–12 and clinical studies 13–15 indicates that cellular senescence is a key pathological process in AD, with SnCs enriched in Aβ–associated brain regions.”
A prolyl oligopeptidase ligand blocks memory deficit in a repeated mild traumatic brain injury model
Uhari-Väänänen, J. K., Eteläinen, T. S., Zuo, C., Lorenzo, F. D., Kilpeläinen, T. P., & Myöhänen, T. T. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115454 · Cited by 3
Gao, Y., Wang, M.-Z., Wang, L. S., Du, Z., Xie, Y.-H., Xu, W.-Q., Wang, Y., Li, R.-H., Guo, D.-B., Zheng, H.-Y., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.016 · Cited by 1
Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration
Vega-García, A., Apolinar, L. M., Feria-Romero, I. A., Campos‐Bedolla, P., Alberto, G.-G. C., Luna‐Munguía, H., Sofía, R.-H., & Orozco-Suárez, S. A. (2026) · Brain Sciences · doi:10.3390/brainsci16101019 · Cited by 1
Analysis and prevention of traffic fatalities and injuries from the perspective of forensic medicine
Kibayashi, K. (2019) · IATSS Research · doi:10.1016/j.iatssr.2019.06.003
Self-citationSenotherapeutics: Experimental therapy of cellular senescence
Justice, J. N., Niedernhofer, L. J., & Orr, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00012-3
Art therapy and brain injury: making the invisible visible
Wolf, D. R., & Rattigan, M. D. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1489813 · Cited by 1
Zhao, J., Liu, Y., Liu, J., Tang, X., Li, C., & Guo, Z. (2025) · Regenerative medicine and dentistry. · doi:10.53941/rmd.2025.100010 · Cited by 2
Beyond survival: What drives senescence in trauma, shock and sepsis?
Mösenlechner, M., Ignatius, A. A., Haffner‐Luntzer, M., Halbgebauer, R., & Huber-Lang, M. S. (2026) · Injury · doi:10.1016/j.injury.2026.113395
Cellular senescence and senolytic therapy in traumatic brain injury
Brann, D. W., Singh, H. D., Wang, J., Lu, Y., Carr, C., & Dhandapani, K. M. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1862748
“…neurons, astrocytes and microglia were also found in the injured cerebrum after TBI, which the authors suggested indicates that cell cycle activation is initiated soon after TBI, and that cells with activated cell cycle rapidly proceed to cellular senescence after TBI (Tominaga et al., 2019).”
Influential
Metadata
- Authors
- Tominaga, T., Shimada, R., Okada, Y., Kawamata, T., & Kibayashi, K.
- Affiliations
- Tokyo Women's Medical University (JP)
- St. Luke's International Hospital (JP)
- Corresponding author
- Shimada, Ryo
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-03-11
- Volume
- 14
- Issue
- 3
- Pages
- e0213673
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6411151
- OpenAlex
- W2921980535
- Cited by
- 66
- References
- 37
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 8 · 2021: 14 · 2020: 5 · 2019: 4
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Japan Society for the Promotion of Science (16K09220, 19H03917)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Keywords
- traumatic brain injury, cellular senescence, senescence-associated β-galactosidase, controlled cortical impact, cerebral contusion, cell cycle markers, senescence-associated secretory phenotype, DNA damage response, neurons, astrocytes, microglia, mouse model
- MeSH terms
- Brain Injuries, Traumatic, Animals, Autophagy, beta-Galactosidase, Disease Models, Animal, Male, Mice, Inbred C57BL, Neurons, Signal Transduction, Cellular Senescence, Apoptosis, Proliferating Cell Nuclear Antigen, Cyclin D1, Gene Expression Profiling, Mice, Cerebrum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.